JDBRX
Price
$48.98
Change
+$0.14 (+0.29%)
Updated
Jul 25 closing price
Net Assets
27.03B
RLEFX
Price
$37.17
Change
+$0.07 (+0.19%)
Updated
Jul 25 closing price
Net Assets
254.37B
Interact to see
Advertisement

JDBRX vs RLEFX

Header iconJDBRX vs RLEFX Comparison
Open Charts JDBRX vs RLEFXBanner chart's image
Janus Henderson Balanced R
Price$48.98
Change+$0.14 (+0.29%)
VolumeN/A
Net Assets27.03B
American Funds American Balanced R5E
Price$37.17
Change+$0.07 (+0.19%)
VolumeN/A
Net Assets254.37B
JDBRX vs RLEFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JDBRX vs. RLEFX commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDBRX is a StrongBuy and RLEFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 254B vs. JDBRX (27B). RLEFX pays higher dividends than JDBRX: RLEFX (2.01) vs JDBRX (1.26). JDBRX was incepted earlier than RLEFX: JDBRX (16 years) vs RLEFX (10 years). JDBRX (1.31) is less costly to investors than RLEFX (0.39). JDBRX is a more actively managed with annual turnover of: 76.00 vs. RLEFX (44.00). RLEFX has a lower initial minimum investment than JDBRX: RLEFX (250) vs JDBRX (2500). RLEFX (10.46) and JDBRX (10.01) have marching annual gain over last year. RLEFX return over 5 years is better than : 40.77 vs. JDBRX (38.68).
JDBRXRLEFXJDBRX / RLEFX
Total Expense Ratio1.310.39336%
Annual Report Gross Expense Ratio1.310.39336%
Fund Existence16 years10 years-
Gain YTD9.0269.13399%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets27B254B11%
Annual Yield % from dividends1.262.0163%
Returns for 1 year10.0110.4696%
Returns for 3 years32.7735.4293%
Returns for 5 years38.6840.7795%
Returns for 10 years79.04N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SVRA2.580.03
+1.18%
Savara
WEX175.621.52
+0.87%
WEX
CGON26.10-0.04
-0.15%
CG Oncology
LFVN13.71-0.27
-1.93%
Lifevantage Corp
ISPC1.07-0.03
-2.79%
iSpecimen Inc